To target or not to target viral antigens in HBV related HCC?

Journal of Hepatology

Volumn 62, Issue 6, 2015, Pages 1449-1450

  Buschow, Sonja I ^a   Sprengers, Dave ^a   Woltman, Andrea M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYPICAN 3; HEPATITIS B SURFACE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS DNA; VIRUS PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; TACROLIMUS;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CELL ENGINEERING; CHRONIC HEPATITIS B; DEGRANULATION; HEPATITIS B VIRUS; HUMAN; HUMAN GENOME; LETTER; LIVER; LIVER CELL; LIVER CELL CARCINOMA; LIVER GRAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION; STABLE EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THERAPY EFFECT; TUMOR RECURRENCE; IMMUNOTHERAPY; LIVER TUMOR; MALE; METABOLISM; PATHOLOGY; PROCEDURES; SECONDARY;

CARCINOMA, HEPATOCELLULAR; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOTHERAPY; LIVER NEOPLASMS; MALE; RECEPTORS, ANTIGEN, T-CELL; TACROLIMUS;

EID: 84929605728     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.01.043     Document Type: Letter

References (8)

1. W. Qasim, M. Brunetto, A.J. Gehring, S.A. Xue, A. Schurich, and A. Khakpoor Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient J Hepatol 62 2015 486 491
2. L.C. Faria, M. Gigou, A.M. Roque-Afonso, M. Sebagh, B. Roche, and G. Fallot Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation Gastroenterology 134 2008 1890 1899 quiz 2155
3. C. Brechot, D. Gozuacik, Y. Murakami, and P. Paterlini-Brechot Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) Semin Cancer Biol 10 2000 211 231
4. W.K. Sung, H. Zheng, S. Li, R. Chen, X. Liu, and Y. Li Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma Nat Genet 44 2012 765 769
5. G. Amaddeo, Q. Cao, Y. Ladeiro, S. Imbeaud, J.C. Nault, and D. Jaoui Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas Gut 64 2015 820 829
6. A.F. Fernandez, C. Rosales, P. Lopez-Nieva, O. Grana, E. Ballestar, and S. Ropero The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer Genome Res 19 2009 438 451
7. R.A. Morgan, J.C. Yang, M. Kitano, M.E. Dudley, C.M. Laurencot, and S.A. Rosenberg Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 Mol Ther 18 2010 843 851
8. S. Koh, and A. Bertoletti Cancer immunotherapy: targeting the difference J Hepatol 61 2014 1175 1177